L3VLUP
ProSign in

PACB · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

PACBJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • PACB
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterPACBJNJ
Q3 20207 holders, $363m30 holders, $26.2bn
Q4 20207 holders, $979m32 holders, $26.6bn
Q1 20215 holders, $879m31 holders, $25.3bn
Q2 20218 holders, $960m37 holders, $25.6bn
Q3 20217 holders, $758m40 holders, $24.1bn
Q4 20214 holders, $651m33 holders, $25.2bn
Q1 20226 holders, $330m35 holders, $28.2bn
Q2 20226 holders, $211m33 holders, $26.9bn
Q3 20224 holders, $203m36 holders, $25.4bn
Q4 20225 holders, $320m35 holders, $27.6bn
Q1 20237 holders, $561m42 holders, $24.5bn
Q2 20238 holders, $629m38 holders, $25.0bn
Q3 20236 holders, $405m37 holders, $18.9bn
Q4 20235 holders, $503m31 holders, $19.0bn
Q1 20245 holders, $164m32 holders, $19.7bn
Q2 20244 holders, $53m35 holders, $20.4bn
Q3 20244 holders, $66m28 holders, $22.3bn
Q4 20244 holders, $71m37 holders, $20.4bn
Q1 20253 holders, $44m32 holders, $20.5bn
Q2 20252 holders, $45m31 holders, $18.4bn
Q3 20252 holders, $40m32 holders, $23.7bn
Q4 20254 holders, $71m29 holders, $27.8bn
Q1 20262 holders, $48m34 holders, $35.6bn
Q2 20262 holders, $50m33 holders, $39.1bn
PACB

Pacific Biosciences of Calif

Holders
2
Reported value
$45m
Buyers
0
Sellers
2

Breadth -2 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
31
Reported value
$18.4bn
Buyers
15
Sellers
16

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only PACB (2)

ARK Investment Management LLC, Farallon Capital Management LLC

Only JNJ (31)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, Quantbot Technologies LP, Renaissance Technologies LLC, T. Rowe Price Associates Inc, and 6 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →